期刊文献+

高碘对金属硫蛋白Ⅰ/Ⅱ敲除小鼠甲状腺线粒体超氧化物生成的影响 被引量:1

Effects of high concentrations of iodide exposure on mitochondrial superoxide production in the thyroid of metallothionein Ⅰ/Ⅱ knockout mice
原文传递
导出
摘要 目的观察高碘对金属硫蛋白Ⅰ/Ⅱ敲除(MT-Ⅰ/ⅡKO)小鼠甲状腺线粒体超氧化物生成的影响。方法利用6-8周龄健康雄性MT-Ⅰ/ⅡKO小鼠和同源对照(WT)小鼠的甲状腺组织,制备甲状腺细胞悬液,分别用10-4、10-3、10-2mol/L碘化钾(KI)和10-3mol/L过氧化氢(H2O2)处理2h,并以无KI或H2O2处理作为对照。利用甲基噻唑基四唑(MTT)法检测细胞活力,酶联免疫吸附试验(ELISA)法检测培养液中乳酸脱氢酶(LDH)含量.利用MitoSOX探针通过流式细胞术检测甲状腺细胞线粒体超氧化物生成。结果与对照组[(100.00±0.00)%、(100.00±0.00)%]比较,10-4、10-3、10-2mol/LKI组和10-3mol/LH2O2组WT、MT-Ⅰ/ⅡKO小鼠甲状腺细胞活力[(73.63±2.05)%、(72.41±2.26)%、(69.63±2.29)%、(44.90±2.93)%和(65.40±2.39)%、(64,51±2.27)%、(61.48±2.33)%、(40.80±2.76)%]均显著下降(P均〈0.05),且MT-Ⅰ/ⅡKO小鼠与WT小鼠相比,细胞活力下降更加明显(P均〈0.05)。与对照组[(1995.28±30.52)、(2004.96±19.71)U/L]比较,10-4、10-3、10-2mol/LKI组和10-3mol/LH2O2组WT和MT-Ⅰ/ⅡKO小鼠甲状腺细胞培养液中LDH含量[(2809.22±156.53)、(2850.80±137.83)、(2920.45±152.92)、(4487.49±130.67)U/L和(3261.06±120.44)、(3474.19±142.15)、(3597.08±150.86)、(4706.64±148.57)U/L]均显著升高(P均〈0.05),且MT-Ⅰ/ⅡKO小鼠与WT小鼠相比,LDH含量升高更加明显(P均〈0.05)。与对照组(26.49±7.66、37.11±8.48)比较,10-2mol/LKI组和100mol/LH202组WT、MT-Ⅰ/ⅡKO小鼠甲状腺细胞线粒体超氧化物生成(58.96±5.1l、87.95±4.25和71.21±5.55、99.76±4.42)明显增加(P均〈0.05);且MT-Ⅰ/ⅡKO小鼠与WT小鼠相比,线粒体超氧化物生成增加更加明显(P均〈0.05)。结论高碘(10-2mol/L)和10-3mol/LH2O2可诱导WT和MT-Ⅰ/ⅡKO小鼠甲状腺细胞线粒体超氧化物生成增多,细胞活力下降.LDH分泌增加:MT-Ⅰ/ⅡKO小鼠较WT小鼠甲状腺线粒体超氧化物生成增加更明显。提示MT-Ⅰ/Ⅱ在对抗氧化应激方面具有一定作用。 Objective To investigate the effects of high concentrations of iodide exposure on mitochondrial superoxide production, cell viability and cell damage in the thyroid of metallothionein Ⅰ/Ⅱ knockout (MT-Ⅰ/Ⅱ KO) mice and corresponding wild type (WT) mice. Methods Thyroid cell suspension of six to eight weeks old healthy male MT-Ⅰ/Ⅱ KO mice and WT mice were prepared. The thyroid cells were treated with high concentrations ( 10-4, 10-3, 10-2 mol/L) of potassium iodide (KI), or 10-3 mol/L hydrogen peroxide (H2O2) for 2 hour, respectively. Cell viability was evaluated with methyl thiazolyl tetrazolium (MTT) assay. Lactate dehydrogenase (LDH) level in cell culture medium was detected by enzyme-linked immunosorbent assay (ELISA). Mitochondrial superoxide production in the thyroid cells was measured by flow cytometry using a fluorescent probe, mitochondrial superoxide(MitoSOX). Results Compared to the control group[(100.00 ± 0.00)%, (100.00 ± 0.00)%], the cell viability of 10-4, 10-3, 10-2 mol/L KI and 10-3 mol/L H2O2 exposure groups were significantly decreased in the thyroid cells of both WT [(73.63 ± 2.05)%, (72.41 ± 2.26)%, (69.63 ± 2.29)%, (44.90 ± 2.93)%] and MT- Ⅰ/Ⅱ KOmice[(65.40 ± 2.39)%,(64.51 ± 2.27)%,(61.48 ± 2.33)%, (40.80± 2.76)%, all P〈 0.05]. Compared to the control group[ (1 995.28 ± 30.52), (2 004.96 ± 19.71)U/L], significantly increased LDH activities were detected in the thyroid cells of WT [(2 809.22 ± 156.53), (2 850.80 ± 137.83), (2 920.45 ± 152.92), (4 487.49 ± 130.67)U/L] and MT-Ⅰ/ⅡKO mice[(3 261.06± 120.44),(3 474.19 ± 142.15), (3 597.08 ± 150.86), (4 706.64 ± 148.57)U/L, all P 〈 0.05]. Compared to the control group (26.49 ± 7.66, 37.11 ± 8.48), the MitoSOX red fluorescence intensities of 10-2 mol/L KI and 10-3 mol/L H2O2 groups were significantly increased in WT mice(58.96±5.11, 87.95 ± 4.25) and MT- Ⅰ/ⅡKO mice(71.21 ± 5.55, 99.76 ± 4.42) by flow cytometry (all P 〈 0.05). Compared to the thyroid cells in WT mice, significantly decreased cell viability (all P 〈 0.05), significantly increased LDH activity(all P 〈 0.05) and significantly increased MitoSOX red fluorescence intensity by flow cytometry (all P 〈 0.05) were detected in the thyroid cells of MT-Ⅰ/Ⅱ KO mice following treatment with KI or H2O2. Conclusions High concentrations of iodide( 10-2 mol/L) and 10-3 mol/L H2O2 may lead to significant increase of mitochondrial superoxide production and LDH activity, decrease of cell viability in both WT and MT-Ⅰ/Ⅱ KO mice. More significant increase of superoxide production is detected in MT- Ⅰ/Ⅱ KO mice, indicating the potential protective role of metallothionein in the thyroid cells of WT mice.
出处 《中华地方病学杂志》 CAS CSCD 北大核心 2014年第3期258-262,共5页 Chinese Journal of Endemiology
基金 国家自然科学基金(81273009) 天津市应用基础及前沿技术研究计划(09JCYBJC11700)
关键词 甲状腺 超氧化物 线粒体 过氧化氢 金属硫蛋白Ⅰ Ⅱ基因敲除 Iodine Thyroid gland Superoxide Mitochondrial Hydrogenpotoxide Metallothionein- Ⅰ/Ⅱ knockout
  • 相关文献

参考文献33

  • 1Nicola JP,Reyna-Neyra A,Carrasco N. Dietary iodide controls its own absorption through post-transcriptional regulation of the intestinal Na+/I-symporter[J].JOURNAL OF PHYSIOLOGY,2012,(Pt 23):6013-6026.
  • 2Rostami R,Beiranvend A,Nourooz-Zadeh J. Nutritional iodine status in gestation and its relation to geographic features in Urmia County of northwest Iran[J].Food and Nutrition Bulletin,2012,(04):267-272.
  • 3符兆胤,张嘉越.碘盐与碘致甲状腺疾病的现状[J].医学综述,2009,15(10):1520-1523. 被引量:17
  • 4Zhao LN,Xu J,Peng XL. Dose and time-dependent hypercholesterolemic effects of iodine excess via TRbetal-mediated down regulationof hepatic LDLr gene expression[J].EUROPEAN JOURNAL OF NUTRITION,2010,(05):257-265.
  • 5Roti E,Uberti ED. Iodine excess and hyperthyroidism[J].THYROID,2001,(05):493-500.
  • 6Laurberg P,Pedersen KM,Hreidarsson A. Iodine intake and the pattern of thyroid disorders:a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland,Denmark[J].Journal of Clinical Endocrinology and Metabolism,1998,(03):765-769.
  • 7Bürgi H. Iodine excess[J].Best Practice and Research Clinical Endocrinology and Metablism,2010,(01):107-115.
  • 8Teng W,Shan Z,Teng X. Effect of iodine intake on thyroid diseases in China[J].New England Journal of Medicine,2006,(26):2783-2793.
  • 9Rose NR,Bonita R,Burek CL. Iodine:an environmental.trigger of thyroiditis[J].Autoimmunity Reviews,2002,(1-2):97-103.
  • 10Laurberg P,Cerqueira C,Ovesen L. Iodine intake as a determinant of thyroid disorders in populations[J].Best Practice and Research Clinical Endocrinology and Metablism,2010,(01):13-27.

二级参考文献71

  • 1李昌祁,阴慧清,张春凯,董京林,赵宝贵,陈苏过,史光文,肖全章,闰桂珍,蔡福祥,何香珍,姜淑文,张东友,崔淑梅.大庆地区十万人群格雷夫斯病流行病学调查[J].中华医学杂志,1996,76(6):443-446. 被引量:29
  • 2李玉姝.碘过量与甲状腺疾病[J].中国实用乡村医生杂志,2007,14(5):3-4. 被引量:6
  • 3Hoption Cann SA. Hypothesis:Dietary Iodine Intake in the Etiology of Cardiovascular Disease [ J ]. J Am Coll Nutr,2006,25 ( 1 ) : 1-11.
  • 4Teng WP, Shan ZY, Teng XC, et al. Effect of iodine intake on thyroid diseases in China [ J ]. N Engl J Med,2006,354:2783-2793.
  • 5WHO, ICCIDD, UNICEF. Indicators for assessing iodine deficiency disorders and their control through saik iodization [ S ]. Geneva: World Health Organization, 1994.
  • 6Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged [ J ]. J Clin Endocrinol Metab, 2005,90 ( 9 ) : 5489 -5496.
  • 7Dunn JT, Semigran M J, Delange F. The prevention and management of iodine induced hyperthyroidism and its cardiac features [ J]. Thyroid, 1998,8 ( 1 ) :101-106.
  • 8Brauer VF, Below H, Kramer A,et al. The role of thioeyanate in the etiology of goiter in an industrial metropolitan area[J]. Eur J Endocrinol, 2006,154 ( 2 ) : 229 -235.
  • 9Dillmann WH. Cellular action of thyroid hormone on the heart[ J]. Thyroid, 2002,12 ( 6 ) :447-452.
  • 10Kasagi K, Iwata M, Misaki T, et al. Effect of iodine restriction on thyroid function in patients with primary hypothyroidism[ J]. Thyroid,2003,13 (6) :561-567.

共引文献60

同被引文献14

  • 1石佩,崔玉玲.高碘和甲状腺球蛋白诱发实验性自身免疫性甲状腺炎的研究[J].长治医学院学报,2006,20(1):12-13. 被引量:14
  • 2Kuboyama N, Zhao J, Zhang L, et al. Effect of low level laser irradiation on CXCR3 gene expression in rheumatoid arthritis joint[J]. J Hard Tissue Biology,2010,19(3):141-146.
  • 3Danilovic DL, Mendes-Correa MC, Chammas MC, et al. Thyroid disturbance related to chronic hepatitis C infection: role of CXCLIO [J]. Endocr J,2013,60(5) :583-590.
  • 4G6mez-Chiarri M, Ortiz A, Gonz61ez-Cuadrado S, et al. Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis [ J ]. Am J Pathol, 1996,148 ( 1 ) : 301-311.
  • 5Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases[J]. Eur J Endocrinol,2004,150(5 ): 605-618.
  • 6Feferman T, Maiti PK, Berrih-Aknin S, et al. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis[J]. J Immunol,2005,174(9):5324-5331.
  • 7Kemp EH, Metcalfe RA, Smith KA, et al. Detection and localization of chemokine gene expression in autoimmune thyroid disease[J]. Clin Endocrinol (Oxf) ,2003,59(2) :207-213.
  • 8Antonelli A, Rotondi M, Fallahi P, et al. High levels of circulating CXC chemol~ine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism[J]. J Clin Endocfinol Metab, 2004,89 ( 11 ) : 5496-5499.
  • 9Romagnani P, Rotondi M, Lazzeri E, et al. Expression of IP- 10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves" disease [ J ]. Am J Pathol, 2002,161 ( 1 ) : 195-206.
  • 10滕晓春,满娜,单忠艳,范晨玲,王红,郭锐,滕卫平.碘致甲状腺滤泡上皮细胞损伤在甲状腺炎发生机制中的探讨[J].中华内科杂志,2008,47(3):193-196. 被引量:4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部